| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.42▲ | 1.41▲ | 1.40▲ | 1.48▼ | 1.51▼ |
| MA10 | 1.41▲ | 1.41▲ | 1.42▲ | 1.46▼ | 1.53▼ |
| MA20 | 1.41▲ | 1.43▼ | 1.44▼ | 1.49▼ | 1.98▼ |
| MA50 | 1.43▼ | 1.46▼ | 1.46▼ | 1.54▼ | 31.09▼ |
| MA100 | 1.46▼ | 1.45▼ | 1.46▼ | 2.02▼ | 23.67▼ |
| MA200 | 1.46▼ | 1.47▼ | 1.53▼ | 16.40▼ | 38.31▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.001▲ | -0.004▼ | 0.003▲ | 1.475▲ |
| RSI | 53.258▲ | 46.640▼ | 45.522▼ | 42.829▼ | 36.012▼ |
| STOCH | 81.250▲ | 39.881 | 24.084 | 48.134 | 14.149▼ |
| WILL %R | -12.500▲ | -50.000 | -74.074 | -85.000▼ | -93.525▼ |
| CCI | 82.773 | 22.590 | -32.442 | -121.637▼ | -83.597 |
|
Monday, November 10, 2025 06:33 AM
"Solid tumors are often difficult to treat because the immune system within the tumor gets switched off," said Michelle H. Nelson, PhD, Director of Immunobiology at Aptevo. "APVO451 is designed to ...
|
|
Thursday, November 06, 2025 07:07 AM
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares were unchanged first thing Thursday. The Seattle-based company, a clinical-stage biotechnology concern focused on developing novel immune-oncology ...
|
|
Thursday, November 06, 2025 05:15 AM
AML across two trials Introduces first trispecific molecules, APVO451 and APVO452, advancing therapies designed to overcome immune suppression in certain solid ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.41 | 1.43 | 1.38 | 1.41 | 711,617 |
| 13/11/25 | 1.52 | 1.54 | 1.415 | 1.45 | 691,823 |
| 12/11/25 | 1.49 | 1.505 | 1.45 | 1.48 | 452,602 |
| 11/11/25 | 1.51 | 1.53 | 1.475 | 1.50 | 486,521 |
| 10/11/25 | 1.48 | 1.56 | 1.44 | 1.56 | 1,193,921 |
| 07/11/25 | 1.41 | 1.50 | 1.39 | 1.47 | 1,213,785 |
| 06/11/25 | 1.42 | 1.53 | 1.41 | 1.47 | 759,759 |
| 05/11/25 | 1.43 | 1.44 | 1.395 | 1.43 | 475,321 |
| 04/11/25 | 1.42 | 1.50 | 1.40 | 1.41 | 607,189 |
| 03/11/25 | 1.53 | 1.53 | 1.45 | 1.47 | 773,743 |
|
|
||||
|
|
||||
|
|